Genomenon

Ann Arbor, MI · Founded 2014 · Privately Held (backing)

Developer of genome interpretation software designed to improve cancer diagnosis and treatment. Genomenon is based in Ann Arbor, MI and was founded in 2014. Its last known valuation is $68 million. It has raised $36.8 million across 4 recorded rounds; the latest was a $5.5 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$68.0M
Total raised
$36.8M
Last round
Early Stage VC
May 2024
How much has Genomenon raised?
$36.8Macross 4 recorded rounds · Aug 2015 – May 2024

Most recently, Genomenon raised $5.5M in its Early Stage VC (May 2024).

Free account
More of Genomenon with a free account
  • ·The complete investor list: 25 names
  • ·Watch Genomenon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Genomenon round by round

4 rounds
May 2024Early Stage VC$5.5MSEC filing▮
30 investors participated
Feb 2022Early Stage VC$20.0MSEC filing▮
23 investors participated
May 2020Seed Round$2.9MSEC filing▮
36 investors participated
Aug 2015Seed Round$446KSEC filing▮
11 investors participated

How much has Genomenon raised?

Genomenon has raised $36.8 million across 4 recorded rounds since 2015. The largest was a $5.5 million early-stage round in May 2024.

Genomenon has filed 4 Form Ds with the SEC since 2015, most recently in May 2024 ($5.5 million sold to 30 investors).

Genomenon investors

25 investors are on record for Genomenon, including Michigan Rise, Invest Detroit Ventures, Innovation Partnerships and Beringea. By type, the record holds 4 venture capital firms and 1 growth equity firm. The early-stage round in May 2024 drew 30 investors.

For fundraisers
Raising for a company like Genomenon?

25 investors have backed Genomenon.

See all 25 investors →

Frequently asked about Genomenon

How much has Genomenon raised?
Genomenon has raised $36.8M in total across 4 recorded funding rounds.
When was Genomenon's last funding round?
Genomenon's most recent recorded round was Early Stage VC in May 2024, raising $5.5M.